Cargando…
A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system
Bispecific T-cell engagers (BiTEs) may break multiple barriers that currently limit the use of immunotherapy in glioblastoma patients. We have recently described a novel BiTE specific for a mutated form of the epidermal growth factor receptor, EGFRvIII, that exerts potent antineoplastic effects agai...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654588/ https://www.ncbi.nlm.nih.gov/pubmed/23734318 http://dx.doi.org/10.4161/onci.23639 |